Mallencheney · Newsroom

RESONEA Selected for Flinn Foundation Bioscience Entrepreneurship Program
Funding Will Support Commercialization of DROWZLE® PRO, the First FDA-Cleared Digital Home Sleep Test, and Consumer Sleep Health Platform

April 30, 2020